172 related articles for article (PubMed ID: 38635412)
1. Cannabis effectiveness on immunologic potency of pulmonary contagion.
Das S; Ghosh A; Karmakar V; Khawas S; Vatsha P; Roy KK; Behera PC
J Basic Clin Physiol Pharmacol; 2024 Apr; ():. PubMed ID: 38635412
[TBL] [Abstract][Full Text] [Related]
2. β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19.
Jha NK; Sharma C; Hashiesh HM; Arunachalam S; Meeran MN; Javed H; Patil CR; Goyal SN; Ojha S
Front Pharmacol; 2021; 12():590201. PubMed ID: 34054510
[TBL] [Abstract][Full Text] [Related]
3. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
Pertwee RG
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
[TBL] [Abstract][Full Text] [Related]
4. Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection.
Janecki M; Graczyk M; Lewandowska AA; Pawlak Ł
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456990
[TBL] [Abstract][Full Text] [Related]
5. The Immunopathology of COVID-19 and the Cannabis Paradigm.
Paland N; Pechkovsky A; Aswad M; Hamza H; Popov T; Shahar E; Louria-Hayon I
Front Immunol; 2021; 12():631233. PubMed ID: 33643316
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?
Onay A; Ertaş A; Süzerer V; Yener İ; Yilmaz MA; Ayaz-Tilkat E; Ekinci R; Bozhan N; Irtegün-Kandemir S
Turk J Biol; 2021; 45(4):570-587. PubMed ID: 34803455
[TBL] [Abstract][Full Text] [Related]
7. The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases.
Kicman A; Pędzińska-Betiuk A; Kozłowska H
Eur J Pharmacol; 2021 Nov; 911():174560. PubMed ID: 34648805
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of cannabinoid agents in animals.
Chaperon F; Thiébot MH
Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the ACE2/Ang-(1-7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19.
Morganstein T; Haidar Z; Trivlidis J; Azuelos I; Huang MJ; Eidelman DH; Baglole CJ
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884756
[TBL] [Abstract][Full Text] [Related]
10. Endocannabinoid-Binding Receptors as Drug Targets.
Gómez-Cañas M; Rodríguez-Cueto C; Satta V; Hernández-Fisac I; Navarro E; Fernández-Ruiz J
Methods Mol Biol; 2023; 2576():67-94. PubMed ID: 36152178
[TBL] [Abstract][Full Text] [Related]
11. Cannabis and Neuropsychiatric Disorders: An Updated Review.
Chayasirisobhon S
Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
[TBL] [Abstract][Full Text] [Related]
12. Dissecting the role of CB
Li X; Hempel BJ; Yang HJ; Han X; Bi GH; Gardner EL; Xi ZX
Eur Neuropsychopharmacol; 2021 Feb; 43():38-51. PubMed ID: 33334652
[TBL] [Abstract][Full Text] [Related]
13. Targeting Cannabinoid Receptor 2 on Peripheral Leukocytes to Attenuate Inflammatory Mechanisms Implicated in HIV-Associated Neurocognitive Disorder.
Rizzo MD; Henriquez JE; Blevins LK; Bach A; Crawford RB; Kaminski NE
J Neuroimmune Pharmacol; 2020 Dec; 15(4):780-793. PubMed ID: 32409991
[TBL] [Abstract][Full Text] [Related]
14. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
15. Cannabis as antivirals.
Sea YL; Gee YJ; Lal SK; Choo WS
J Appl Microbiol; 2023 Jan; 134(1):. PubMed ID: 36626776
[TBL] [Abstract][Full Text] [Related]
16. Fighting the storm: could novel anti-TNFα and anti-IL-6
Kovalchuk A; Wang B; Li D; Rodriguez-Juarez R; Ilnytskyy S; Kovalchuk I; Kovalchuk O
Aging (Albany NY); 2021 Jan; 13(2):1571-1590. PubMed ID: 33465050
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids Receptors in COVID-19: Perpetrators and Victims.
Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Batiha GE
Curr Med Chem; 2023; 30(34):3832-3845. PubMed ID: 36043749
[TBL] [Abstract][Full Text] [Related]
18. The Role of Cannabinoid Receptor 1 in the Immunopathology of Respiratory Syncytial Virus.
Tahamtan A; Tavakoli-Yaraki M; Shadab A; Rezaei F; Marashi SM; Shokri F; Mokhatri-Azad T; Salimi V
Viral Immunol; 2018 May; 31(4):292-298. PubMed ID: 29461930
[TBL] [Abstract][Full Text] [Related]
19. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB
Wang XF; Galaj E; Bi GH; Zhang C; He Y; Zhan J; Bauman MH; Gardner EL; Xi ZX
Br J Pharmacol; 2020 Apr; 177(8):1865-1880. PubMed ID: 31877572
[TBL] [Abstract][Full Text] [Related]
20. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
